REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Innovative Pharma Baltics (Lithuania)

Main Activities: All Other Miscellaneous Food Manufacturing | Fish and Seafood Merchant Wholesalers
Secondary Activities: Other Food Manufacturing
Full name: UAB Innovative Pharma Baltics Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Innovative Pharma Baltics is an enterprise in Lithuania, with the main office in Vilnius. The company operates in the All Other Miscellaneous Food Manufacturing sector. UAB Innovative Pharma Baltics was incorporated on April 08, 2008. It currently has a total number of 26 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 49.83% in 2024. UAB Innovative Pharma Baltics’s net profit margin decreased by 2.18% in 2024.

Headquarters
Mokslininku g. 6A
Vilnius; Vilnius county; Postal Code: LT-08412

Contact Details: Purchase the UAB Innovative Pharma Baltics report to view the information.

Basic Information
Total Employees:
Purchase the UAB Innovative Pharma Baltics report to view the information.
Registered Capital:
Purchase the UAB Innovative Pharma Baltics report to view the information.
Financial Auditors:
Purchase the UAB Innovative Pharma Baltics report to view the information.
Incorporation Date:
April 08, 2008
Key Executives
Purchase this report to view the information.
Member of the Management Board
Company Performance
Financial values in the chart are available after UAB Innovative Pharma Baltics report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
49.83%
Total operating revenue
49.83%
Net Profit (Loss) for the Period
-12.35%
Total Equity
8.13%
Net Profit Margin
-2.18%
Return on Equity (ROE)
-1.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?